Please login to the form below

Not currently logged in
Email:
Password:

Pharmaceutical Market Europe - November 2013

PME November 2013In this issue we talk with …

Lilly’s Dr Mike Hutton

The company's chief scientific officer for neurodegenerative diseases talks about the future for Alzheimer’s research … 

And we take a look at …

Value-added services

Going ‘beyond the pill’ offers new opportunities and advantages for pharma …

Medical devices regulation

European changes come at a critical time for the sector …  

The ASEAN vaccines market

Do domestic players in the South-East Asian bloc present a threat or an opportunity …

Counting what counts

The value of investing in communications analytics …   

Also with this issue …

Digital Intelligence 

Mobile health apps and their, as yet, unrealised potential

R&D Pipeline

New therapies for major depressive disorder

Innovation Update

European pharma job cuts are releasing talent that's driving the development of bioclusters …

and in addition ...

 Strategic communications for orphan drugs for orphan drugs


... Strategic communications for orphan drugs

PME's next Orphan Drugs and Rare Diseases supplement tackles how to meet communications challenges …

 

 

 

... Inside: CROs

PME’s annual contract research guide; includes features on adaptive trials, digital technology and extensive CRO capability charts …



 

 

View PME November 2013 online

Register here to receive email notification of future digital editions of PME or contact the subscriptions department to enquire about receiving a print copy of the magazine. More PMLiVE digital editions can be found here.

PME is also available to download as an app for iPhone, iPad, Android and Kindle Fire

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
VCCP Health

We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...

Infographics